- Home
- KROS vs CYH Comparison
KROS vs CYH Comparison
Compare KROS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | CYH |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 432.2M |
| IPO Year | 2020 | 1991 |
Fundamental Metrics
Financial Performance| Metric | KROS | CYH |
|---|---|---|
| Price | $17.73 | $3.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 7 |
| Target Price | ★ $22.20 | $3.73 |
| AVG Volume (30 Days) | 597.1K | ★ 1.3M |
| Earning Date | 02-25-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 1.57 | ★ 2.47 |
| Revenue | $246,718,000.00 | ★ $12,644,000,000.00 |
| Revenue This Year | $6,924.79 | $0.04 |
| Revenue Next Year | N/A | $0.86 |
| P/E Ratio | $11.38 | ★ $1.32 |
| Revenue Growth | ★ 37798.31 | 0.74 |
| 52 Week Low | $9.12 | $2.24 |
| 52 Week High | $22.55 | $4.47 |
Technical Indicators
Market Signals| Indicator | KROS | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 35.45 | 54.53 |
| Support Level | $19.76 | $3.04 |
| Resistance Level | $21.76 | $3.25 |
| Average True Range (ATR) | 0.81 | 0.10 |
| MACD | -0.54 | 0.01 |
| Stochastic Oscillator | 5.18 | 100.00 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.